Douglas Eby is the inaugural Senior Fellow for the Innovative Funding Models Project. Doug’s role is to advance the work of the Project by developing a policy/research agenda, planning the convening of the working group, co-authoring a report on the working group's findings, and being available as a resource for interested members of the Harvard community.
As a 2017 Fellow in Harvard University’s Advanced Leadership Initiative, Doug’s efforts have been focused on innovative financing models to meet the unprecedented gap that currently exists in translational research. His work at Harvard led to the formation of Cambridge Science Corporation, where Doug serves as the Chief Executive Officer. Cambridge Science Corporation’s mission is to improve global health by accelerating the pace of medical technology innovation.
Prior to founding Cambridge Science, Doug worked in the investment management industry. He has extensive experience in the health care sector as an institutional investor across all stages of the capital continuum: public, private equity, venture capital, and angel startup financings. Most recently, Doug was the President and Portfolio Manager for an investment advisor managing institutional assets for clients in the US equity markets deploying a long-term value-based strategy. Doug has served as a director of several NYSE listed public companies including the Markel Corporation, Level 3 Communications, and CBRE Realty Finance, and as an advisory director of the Student Loan Marketing Association (Sallie Mae). He has served on the boards of numerous nonprofits including Suburban Hospital-Johns Hopkins Medicine, where he was chairman of the hospital's investment committee, and the Boys and Girls Clubs of Greater Washington, DC, where he served as chairman of the board.
Doug Eby graduated with a BA in economics from Catholic University, Washington, DC, and earned an MBA in finance and accounting from Indiana University in Bloomington, Indiana.